CONMED Corp (CNMD): Scopia Capital Isn’t Done Buying Shares

Page 16 of 22 SEC Filing

E.	Scopia International

(a)

As of the close of business on March 8, 2016, Scopia International beneficially owned 95,331 Shares.

Percentage: Less than 1%

(b)

1. Sole power to vote or direct vote: 95,331

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 95,331

4. Shared power to dispose or direct the disposition: 0

(c)

The transactions in the securities of the Issuer by Scopia International since the filing of Amendment No. 1 to the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

F.	Scopia PX International

(a)

As of the close of business on March 8, 2016, Scopia PX International beneficially owned 688,144 Shares.

Percentage: Approximately 2.5%

(b)

1. Sole power to vote or direct vote: 688,144

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 688,144

4. Shared power to dispose or direct the disposition: 0

(c)

The transactions in the securities of the Issuer by Scopia PX International since the filing of Amendment No. 1 to the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

G.           Scopia Health International

(a)

As of the close of business on March 8, 2016, Scopia Health International beneficially owned 300,900 Shares.

Percentage: Approximately 1.1%

(b)

1. Sole power to vote or direct vote: 300,900

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 300,900

4. Shared power to dispose or direct the disposition: 0

(c)

The transactions in the securities of the Issuer by Scopia Health International since the filing of Amendment No. 1 to the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

Follow Conmed Corp (NASDAQ:CNMD)

Follow Conmed Corp (NASDAQ:CNMD)

---

or

Subscribe with Google

We may use your email to send marketing emails about our services. Click here to read our privacy policy.